Evaluation of the effect of D-002, a mixture of beeswax alcohols, on osteoarthritis symptoms - PubMed (original) (raw)
Randomized Controlled Trial
. 2014 Mar;29(2):191-202.
doi: 10.3904/kjim.2014.29.2.191. Epub 2014 Feb 27.
Affiliations
- PMID: 24648802
- PMCID: PMC3956989
- DOI: 10.3904/kjim.2014.29.2.191
Randomized Controlled Trial
Evaluation of the effect of D-002, a mixture of beeswax alcohols, on osteoarthritis symptoms
Roberto Puente et al. Korean J Intern Med. 2014 Mar.
Abstract
Background/aims: Nonsteroidal anti-inflammatory drugs relieve osteoarthritis (OA) symptoms but cause adverse effects. D-002, a mixture of beeswax alcohols, is effective against experimental OA. A pilot study found that D-002 (50 mg/day) for 8 weeks improves OA symptoms. The aim of this study was to investigate the effects of D-002 (50 to 100 mg/day) administered for 6 weeks on OA symptoms.
Methods: Patients with OA symptoms were double-blindly randomized to D-002 (50 mg) or placebo for 6 weeks. Symptoms were assessed by the Western Ontario and McMaster Individual Osteoarthritis Index (WOMAC) and the visual analog scale (VAS) scores. Patients without symptom improvement at week 3 were titrated to two daily tablets. The primary outcome was the total WOMAC score. WOMAC pain, joint stiffness and physical function scores, VAS score, and use of rescue medications were secondary outcomes.
Results: All randomized patients (n = 60) completed the study, and 23 experienced dose titration (two in the D-002 and 21 in the placebo groups). At study completion, D-002 reduced total WOMAC (65.4%), pain (54.9%), joint stiffness (76.8%), and physical function (66.9%) WOMAC scores, and the VAS score (46.8%) versus placebo. These reductions were significant beginning in the second week, and became enhanced during the trial. The use of rescue medication by the D-002 (6/30) group was lower than that in the placebo (17/30) group. The treatment was well tolerated. Seven patients (two in the D-002 and five in the placebo group) reported adverse events.
Conclusions: These results indicate that D-002 (50 to 100 mg/day) for 6 weeks ameliorated arthritic symptoms and was well tolerated.
Keywords: Anti-inflammatory agents; Beeswax alcohols; D 002; Osteoarthritis; Western Ontario and McMaster Individual Osteoarthritis Index score.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment in
- Can natural products serve as potential treatments for osteoarthritis?
Kim HS. Kim HS. Korean J Intern Med. 2014 Mar;29(2):173-5. doi: 10.3904/kjim.2014.29.2.173. Epub 2014 Feb 27. Korean J Intern Med. 2014. PMID: 24648799 Free PMC article. No abstract available.
Similar articles
- Effects of a Combined Therapy With D-002 (Beeswax Alcohols) Plus D-003 (Sugarcane Wax Acids) on Osteoarthritis Symptoms.
Puente RA, Illnait J, Mas RM, Carbajal DM, Mendoza S, Ceballos A, Fernández JC, Mesa M, Reyes P, Ruiz D. Puente RA, et al. Altern Ther Health Med. 2016 Jun;22 Suppl 2:15-23. Altern Ther Health Med. 2016. PMID: 27433837 Clinical Trial. - Comparison of the efficacy and tolerability of chondroitin plus glucosamine and D-002 (beeswax alcohols) in subjects with osteoarthritis symptoms.
Puente R, Illnait J, Mas R, López E, Mendoza S, Carbajal D, Fernández J, Fernández L, Mesa M, Reyes P, Ruiz D. Puente R, et al. Rev Fac Cien Med Univ Nac Cordoba. 2017;74(2):107-118. Rev Fac Cien Med Univ Nac Cordoba. 2017. PMID: 28657529 Clinical Trial. - Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
Kulkarni MP, Shakeel A, Shinde BS, Rosenbloom RA. Kulkarni MP, et al. Am J Ther. 2011 Mar-Apr;18(2):170-7. doi: 10.1097/MJT.0b013e318209df49. Am J Ther. 2011. PMID: 21317618 Clinical Trial. - Chondroitin for osteoarthritis.
Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Singh JA, et al. Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD005614. doi: 10.1002/14651858.CD005614.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629804 Free PMC article. Review.
Cited by
- D-002 (beeswax alcohols): concurrent joint health benefits and gastroprotection.
Molina V, Mas R, Carbajal D. Molina V, et al. Indian J Pharm Sci. 2015 Mar-Apr;77(2):127-34. doi: 10.4103/0250-474x.156542. Indian J Pharm Sci. 2015. PMID: 26009643 Free PMC article. Review. - A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.
Mathieu S, Soubrier M, Peirs C, Monfoulet LE, Boirie Y, Tournadre A. Mathieu S, et al. Nutrients. 2022 Apr 12;14(8):1607. doi: 10.3390/nu14081607. Nutrients. 2022. PMID: 35458170 Free PMC article. Review. - Enhancement of Antioxidant and Anti-Glycation Properties of Beeswax Alcohol in Reconstituted High-Density Lipoprotein: Safeguarding against Carboxymethyllysine Toxicity in Zebrafish.
Cho KH, Baek SH, Nam HS, Bahuguna A. Cho KH, et al. Antioxidants (Basel). 2023 Dec 14;12(12):2116. doi: 10.3390/antiox12122116. Antioxidants (Basel). 2023. PMID: 38136235 Free PMC article. - Can natural products serve as potential treatments for osteoarthritis?
Kim HS. Kim HS. Korean J Intern Med. 2014 Mar;29(2):173-5. doi: 10.3904/kjim.2014.29.2.173. Epub 2014 Feb 27. Korean J Intern Med. 2014. PMID: 24648799 Free PMC article. No abstract available.
References
- Lozada C, Steigelfest E. Osteoarthritis. Med Rheumatol. 2010;15:12–23.
- Iagnocco A, Naredo E. Osteoarthritis: research update and clinical applications. Rheumatology (Oxford) 2012;51(Suppl 7):vii2–vii5. - PubMed
- Lee YC, Shmerling RH. The benefit of nonpharmacologic therapy to treat symptomatic osteoarthritis. Curr Rheumatol Rep. 2008;10:5–10. - PubMed
- Bannwarth B. Acetaminophen or NSAIDs for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol. 2006;20:117–129. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical